The Parenteral Nutrition Bags Market is expected to grow at a CAGR of 6.6% from 2024 to 2031 to reach $1.25 billion by 2031, according to Meticulous Research®. The growth of the parenteral nutrition bags market is driven by the growing prevalence of chronic and infectious diseases, the rising global prevalence of malnutrition, the large number of premature births, and the increasing incidence of metabolic disorders. Furthermore, the growing adoption of home healthcare, the rising global geriatric population, and emerging economies are expected to generate growth opportunities for the stakeholders in this market. However, concerns over the infection risks associated with parenteral nutrition restrain the growth of this market. The lack of awareness regarding parenteral nutrition in developing countries is a major challenge impacting the growth of the parenteral nutrition bags market.
Here are the top 10 companies operating in the Parenteral Nutrition Bags Market
Founded in 1839 and headquartered in Melsungen, Germany, B. Braun develops, manufactures, and markets medical technology-based products. The company provides products and services in 15 therapeutic areas and applications grouped into three divisions: Hospital Care, Aesculap, and Avitum. The company offers parenteral nutrition bags through the Hospital Care division. The Hospital Care division offers infusion, nutrition, and pain therapy products.
The company has more than 300 subsidiaries in 64 countries. With its subsidiaries and a strong distribution network, the company has manufacturing sites in Melsungen, Berlin, Denzlingen, Dresden, Glandorf, Tuttlingen (all Germany); Rubí (Spain); Nogent (France); Mirandola (Italy); Nowy Tomyśl (Poland); Gyöngyös (Hungary); Crissier, Escholzmatt, Sempach (all Switzerland); Allentown, Pennsylvania, Florida, Irvine, California (all US); Suzhou (China); Tochigi (Japan); Penang (Malaysia); Hanoi (Vietnam); New Delhi (India); and São Gonçalo (Brazil).
The company’s subsidiaries include B. Braun Medical Inc. (U.S.), B. Braun Medical S.A.S. (France), B. Braun Medical (HK) Ltd. (Hong Kong), and B. Braun Medical (India) Pvt. Ltd., among others.
Baxter International, Inc. (U.S.)
Founded in 1931 and headquartered in Illinois, U.S., Baxter International, Inc. provides essential healthcare products, including respiratory health devices, acute and chronic dialysis therapies; sterile intravenous (IV) solutions; advanced surgical equipment, infusion systems, and devices; parenteral nutrition therapies, and others. The company operates through four business segments, namely Medical Products and Therapies, Healthcare Systems and Technologies, Pharmaceuticals, and Kidney Care. The Medical Products and Therapies segment includes Infusion Therapies and Technologies and Advanced Surgery product categories. The company offers parenteral nutrition bags from the infusion therapies and technologies segment.
The company provides products to end users such as nursing homes, hospitals, rehabilitation centers, home healthcare, and others. The company has distribution facilities in the U.S., Puerto Rico, Japan, Korea, Mexico, New Zealand, Spain, Sweden, Switzerland, UAE, and other countries. Some of the company’s subsidiaries include Baxter Healthcare Corporation (U.S.), Baxter Healthcare Limited (China), Baxter Private Limited (India), and Baxter Healthcare Limited (U.K.), among others.
Founded in 1999 and headquartered in Homburg, Germany, Fresenius Kabi AG, formed by the merging of Fresenius Group’s Pharma division with the business acquired from Pharmacia & Upjohn (Kabi), provides infusion therapy and clinical nutrition products. The company is a subsidiary of Fresenius SE & Co. KGaA (Germany). The company’s product portfolio includes biopharmaceuticals, clinical nutrition, MedTech products, intravenously administered generic drugs (generic IV drugs), and IV fluids. The company offers products from four product categories, namely I.V. Drugs & Infusion Therapy, Medical Nutrition, MedTech, and Biopharma. The company offers parenteral nutrition bags from the I.V. Drugs & Infusion Therapy product category.
The company offers products to the end users such as outpatient clinics, home care, long-term care, and rehabilitation centers. The company has a manufacturing facility in China, France, Germany, Austria, and the Netherlands. The company has a presence in Egypt, UAE, India, China, Norway, Poland, Brazil, the U.S., Canada, and other countries. The company’s subsidiaries include Fresenius Kabi India Pvt. Ltd. (India) and Fresenius Kabi USA (U.S.).
GVS S.p.A. (Italy)
Founded in 1979 and headquartered in Bologna, Italy, GVS S.p.A. manufactures filter solutions for applications in the healthcare & life sciences, energy & mobility, and health & safety sectors. The company operates its business through three business segments, namely Healthcare & Life Sciences, Energy & Mobility, and Health & Safety. The Healthcare & Life Sciences segment consists of Healthcare Liquid, Healthcare Air & Gas, and Laboratory product categories. The Healthcare Liquid product category offers parenteral nutrition bags.
In May 2022, GVS acquired Haemotronic SPA (Italy) and provides parenteral nutrition bags from the acquired company’s portfolio. The company currently has 19 plants in Italy, the U.K., Brazil, the U.S., China, Mexico, Romania, and Puerto Rico and 29 commercial offices globally. It also has nine R&D centers and 58 patent families. GVA has a geographical presence in China, South Korea, Brazil, Peru, Iraq, Saudi Arabia, Russia, the U.S., and other countries.
Founded in 1909 and headquartered in Barcelona, Spain, Grifols, S.A. develops plasma-derived medicines and other biopharmaceutical solutions. The company operates through four business units, namely Plasma Procurement and Biopharma, Diagnostic, Bio Supplies, and Others (Specialty Pharmaceuticals and Hospital Management Solutions). The company offers products for therapeutic areas, including immunology and neurology, pulmonology, hematology, infectious disease, and hepatology/intensive care. The company offers parenteral nutrition bags from hospital management solutions.
The company has 3,487 patents and 14 R&D and innovation centers. The company has manufacturing facilities in Canada, the U.S., Spain, Ireland, and other countries. The company has a presence in Melbourne, China, Egypt, Austria, Germany, the U.S., Canada, and other countries. Some of the subsidiaries of the company include Grifols France S.A.R.L. (France), Grifols Mexico, S.A. de C.V. (Mexico), Grifols USA, LLC (U.S), Grifols Brasil, Ltda. (Brazil), and Grifols UK Ltd. (U.K.), among others.
Meticulous Research in its latest publication on Parenteral Nutrition Bags Market has predicted the growth of 6.6% during the forecast year 2024-2031.
Technolflex (France)
Founded in 1972 and headquartered in France, Technolflex designs and produces medical devices and flexible bags. The company’s products include EVA bags, PVC bags, multi-chamber bags, PP bags, medical connectors, FEP bags, and sterile bags. The company offers bags for nutrition, cell therapies, biopharmaceuticals, diagnosis, animal health, IV therapies, and other solutes. The company also offers turnkey solutions and generic drug dossier services.
The company’s manufacturing facilities are ISO 7 (Class C) and ISO 8 (Class D) certified cleanrooms or Controlled Atmosphere Zones certified. The company has an annual production capacity of 100 million bags and 500 million connectors.
Founded in 1946 and headquartered in Worms, Germany, RENOLIT SE manufactures plastic products, including films, sheets, and other products. The company’s product range includes a wide range of plastic films and other plastic products, as well as related services for various markets and applications, including the automotive, medical & pharmaceutical, home & building, shipping, advertising & packaging sectors. The company operates in Automotive, Healthcare, Home & Building, Maritime, Packaging, Visual Communication, and Wind Energy. The company provides medical and pharmaceutical products through the RENOLIT Healthcare unit.
The company’s healthcare product portfolio includes blood & blood components, biotechnology, IV & pharmacological applications, dialysis, nutrition, ports & caps, secondary packaging, granules, custom-made solutions, tailor-made films, and EMT equipment leasing. The company offers parenteral nutrition bags from the nutrition product category.
The company has four manufacturing facilities across Europe, North America, Asia, and South America. It has a geographical presence in 30 locations, including the U.S., Canada, the U.K., Spain, China, India, and other countries. Some of the regional subsidiaries of the company include RENOLIT India Private Limited (India), RENOLIT Healthcare Beijing (China), RENOLIT Chile SpA (Chile), and RENOLIT Belgium N.V. (Belgium), among others.
Valmed s.r.l. (Italy)
Founded in 2007 and headquartered in Sondrio, Italy, Valmed s.r.l. designs, develops, and manufactures medical devices. The company offers products from three product categories, namely Extension, Bag, Infusion & Transfusion Set. The company offers parenteral nutrition bags from the Bag segment along with enteral nutrition bags, drainage bags, heating bags, and blood cryo-conservation bags.
The company uses high-frequency welding technology to produce bags and components. The company’s quality management systems are compliant with ISO 13485 and MDSAP certification for the U.S., Brazil, Canada, and Australia. The company also has CE and FDA certifications available for medical devices.
Founded in 2011 and headquartered in Saxony, Germany, HEMEDIS GmbH produces medical equipment for the preparation and administration of parenteral nutrition and other diverse mixed infusions. The company’s product range includes mixing and infusion bags, MIBMIX compounders with innovative Fluicheck sensors, tubing systems for compounding, and accessories. The company offers parenteral nutrition bags from the mixing and infusion bags product category. The company offers single-chamber and multi-chamber parenteral nutrition bags.
The company’s quality management system is certified according to DIN EN ISO 13485:2016. Between 2017 to 2020, the company increased its manufacturing capacity, and in 2019, it opened a new logistics center in Germany.
INFRA Srl (Italy)
Founded in 1985 and headquartered in Reggiolo, Italy, INFRA Srl manufactures protective devices, medical components, and biomedical devices. The company offers products for applications such as enema, infusion, urology, clinical nutrition, drain dialysis, and transfusion. The company offers products from three product categories, namely TPN, Chemotherapy, and Enteral. The company offers parenteral nutrition bags from the TPN product category.
The company offers original equipment manufacturing services for components used in the pharmaceutical, medical, diagnostics, and veterinary fields. Its manufacturing facility is certified with ISO9001 and ISO13485 standards, and its products are certified with Directive 93/42 / ECC.
Other players operating in the global parenteral nutrition bags market include Beijing L&Z Medical Technology Development Co., Ltd. (China), Boen Healthcare Co., Ltd. (China), AdvaCare Pharma (U.S.), and Diffuplast S.r.l. (Italy). Apart from these companies, the parenteral nutrition bags market consists of many other smaller companies.
Authoritative Research on the Parenteral Nutrition Bags Market – Global Opportunity Analysis and Industry Forecast (2024-2031)
Need more information? Meticulous Research®’s new report covers each of these companies in much more detail, providing analysis on the following:
- Recent financial performance
- Key products
- Significant company strategies
- Partnerships and acquisitions
The Comprehensive report provides global market size estimates, market share analysis, revenue numbers, and coverage of key issues and trends.